Complicated Pneumonia (CP) in Children in South-East Europe
Recruiting now
Conditions studied: Pneumonia, Necrotizing, Lung Abscess, Empyema, Pleural
In brief
This retrospective observational study aims to evaluate clinical course of complicated community acquired pneumonia in children, particularly focusing on necrotizing pneumonia cases, as well as determination of etiological agents (viruses and bacteria) and its association to severity and outcomes of the disease. Furthermore, therapeutic approach, complications, short-term and long-term outcomes and the prevention of the disease are to be assessed. The study will encompass data from pediatric centers in the South-East Europe willing to participate in the study, encompassing ten-year period of time.
Key facts
- Study ID
- NCT06657898
- Run by
- Aleksandar Sovtic
- People needed
- 300
- Starts
- 2024-05-27
- Expected to finish
- 2025-10-01
- Last updated by the study team
- 2024-10-26
Who can join
Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Children aged 1 month to 18 years of age
- Children diagnosed with complicated community acquired pneumonia (pneumonia with parapneumonic effusion, necrotizing pneumonia and lung abscess)
- Children who were hospitalized from January 1st 2014 to April 30th 2024 and required at least 24 hours of hospital stay
You may not qualify if…
- Children with increased risk for severe lung infections (cystic fibrosis, primary ciliary dyskinesia, immunodeficiencies, congenital lung abnormalities, neurological conditions, chemotherapy)
- Children with hospital-acquired pneumonia
Where it is running
- IMotherChildHealth — Belgrade, Serbia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.